Sartorius AG (SOAGY)
52.70
-1.19
(-2.21%)
USD |
OTCM |
Sep 14, 16:00
Sartorius Enterprise Value : 14.82B for Sept. 14, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 14.82B |
| September 11, 2026 | 15.02B |
| September 10, 2026 | 14.97B |
| September 09, 2026 | 15.19B |
| September 08, 2026 | 15.21B |
| September 04, 2026 | 15.22B |
| September 03, 2026 | 15.55B |
| September 02, 2026 | 15.56B |
| September 01, 2026 | 15.55B |
| August 31, 2026 | 15.67B |
| August 28, 2026 | 15.83B |
| August 27, 2026 | 15.89B |
| August 26, 2026 | 15.59B |
| August 25, 2026 | 15.64B |
| August 24, 2026 | 15.60B |
| August 21, 2026 | 15.82B |
| August 20, 2026 | 15.82B |
| August 19, 2026 | 15.23B |
| August 18, 2026 | 14.89B |
| August 17, 2026 | 15.05B |
| August 14, 2026 | 15.19B |
| August 13, 2026 | 15.21B |
| August 12, 2026 | 15.13B |
| August 11, 2026 | 15.23B |
| August 10, 2026 | 15.24B |
| Date | Value |
|---|---|
| August 07, 2026 | 15.10B |
| August 06, 2026 | 14.87B |
| August 05, 2026 | 14.85B |
| August 04, 2026 | 14.82B |
| August 03, 2026 | 14.82B |
| July 31, 2026 | 14.41B |
| July 30, 2026 | 14.59B |
| July 29, 2026 | 14.61B |
| July 28, 2026 | 14.49B |
| July 27, 2026 | 14.19B |
| July 24, 2026 | 14.33B |
| July 23, 2026 | 14.34B |
| July 22, 2026 | 14.45B |
| July 21, 2026 | 14.35B |
| July 20, 2026 | 15.01B |
| July 17, 2026 | 15.41B |
| July 16, 2026 | 15.38B |
| July 15, 2026 | 15.55B |
| July 14, 2026 | 15.62B |
| July 13, 2026 | 15.52B |
| July 10, 2026 | 15.29B |
| July 09, 2026 | 14.93B |
| July 08, 2026 | 14.44B |
| July 07, 2026 | 14.84B |
| July 06, 2026 | 14.81B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Mesa Laboratories, Inc. | 810.43M |
| Austar Lifesciences Ltd. | -- |
| SCHOTT Pharma AG & Co. KGaA | 3.920B |
| Agilent Technologies, Inc. | 43.58B |
| Bio-Rad Laboratories, Inc. | 9.605B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 107.78M |
| Revenue (Quarterly) | 1.060B |
| Total Expenses (Quarterly) | 983.54M |
| EPS Diluted (Quarterly) | 0.2219 |
| Gross Profit Margin (Quarterly) | 47.50% |
| Profit Margin (Quarterly) | 10.17% |
| Earnings Yield | 1.26% |
| Operating Earnings Yield | 4.06% |
| Normalized Earnings Yield | 1.513 |